BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 8650812)

  • 21. Amiodarone lung toxicity: role of pulmonary function tests.
    Foresti V; Carini L; Lovagnini-Scher CA; Parisio E; Scolari N; Pozzi G; Clini V
    Int J Clin Pharmacol Res; 1987; 7(5):373-80. PubMed ID: 3667010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The diagnostic utility of chest computed tomography scoring for the assessment of amiodarone-induced pulmonary toxicity.
    Kang IS; Kim KJ; Kim Y; Park SH
    Korean J Intern Med; 2014 Nov; 29(6):746-53. PubMed ID: 25378973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amiodarone: review of pulmonary effects and toxicity.
    Papiris SA; Triantafillidou C; Kolilekas L; Markoulaki D; Manali ED
    Drug Saf; 2010 Jul; 33(7):539-58. PubMed ID: 20553056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug induced lung disease--amiodarone in focus.
    Vasić NR; Milenković BA; Pešut DP; Stević RS; Jovanović DM
    Med Pregl; 2014; 67(9-10):334-7. PubMed ID: 25546981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amiodarone-induced pulmonary toxicity mimicking acute pulmonary edema.
    Fabiani I; Tacconi D; Grotti S; Brandini R; Salvadori C; Caremani M; Bolognese L
    J Cardiovasc Med (Hagerstown); 2011 May; 12(5):361-5. PubMed ID: 19924000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary masses in a patient with blue-gray cutaneous hyperpigmentation.
    Facchini G; Forte S; Podda P; Piro F; Carlone S
    Eur Rev Med Pharmacol Sci; 2008; 12(2):113-6. PubMed ID: 18575161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amiodarone lung toxicity in a cardiac transplant candidate initially diagnosed by fine-needle aspiration: cytologic, histologic, and electronmicroscopic findings.
    Omeroglu G; Kalugina Y; Ersahin C; Wojcik EM
    Diagn Cytopathol; 2006 May; 34(5):351-4. PubMed ID: 16604561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute amiodarone-induced pulmonary toxicity: an association of risk factors in a child operated by arterial switch operation.
    Labombarda F; Ou P; Stos B; de Blic J; Villain E; Sidi D
    Congenit Heart Dis; 2008; 3(5):365-7. PubMed ID: 18837818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amiodarone pulmonary toxicity. Amiodarone should be used with caution in patients in intensive care.
    Donaldson L; Grant IS; Naysmith MR; Thomas JS
    BMJ; 1997 Jun; 314(7097):1832. PubMed ID: 9224104
    [No Abstract]   [Full Text] [Related]  

  • 30. Rationale, development, and clinical outcomes of a multidisciplinary amiodarone clinic.
    Sanoski CA; Schoen MD; Gonzalez RC; Avitall B; Bauman JL
    Pharmacotherapy; 1998; 18(6 Pt 2):146S-151S. PubMed ID: 9855347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monitoring the use of amiodarone: compliance with guidelines.
    Burgess C; Blaikie A; Ingham T; Robinson G; Narasimhan S
    Intern Med J; 2006 May; 36(5):289-93. PubMed ID: 16650193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amiodarone-induced acute lung toxicity in an ICU setting.
    Skroubis G; Galiatsou E; Metafratzi Z; Karahaliou A; Kitsakos A; Nakos G
    Acta Anaesthesiol Scand; 2005 Apr; 49(4):569-71. PubMed ID: 15777308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amiodarone-induced pulmonary toxicity. Predisposing factors, clinical symptoms and treatment.
    Jessurun GA; Boersma WG; Crijns HJ
    Drug Saf; 1998 May; 18(5):339-44. PubMed ID: 9589845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Multiple pulmonary nodules and amiodarone. KL-6 as a new diagnostic tool].
    Bernal Morell E; Hernández Madrid A; Marín Marín I; Rodríguez Pena R; González Gordaliza MC; Moro C
    Rev Esp Cardiol; 2005 Apr; 58(4):447-9. PubMed ID: 15847740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Management of severe amiodarone-induced pneumopathy using inhaled nitric oxide].
    Fellahi JL; Texereau J; Chironi G; Qanadli SD; Jardin F
    Rev Pneumol Clin; 1997; 53(4):210-2. PubMed ID: 9616822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between amiodarone-induced subclinical lung toxicity and Th1/Th2 balance.
    Kuruma T; Maruyama T; Hiramatsu S; Yasuda Y; Yasuda S; Odashiro K; Harada M
    Int J Cardiol; 2009 May; 134(2):224-30. PubMed ID: 18584899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Amiodarone pulmonary toxicity].
    Reĭngardene DI; Azaravichene AP; Korobkova IZ
    Vestn Rentgenol Radiol; 2002; (1):43-7. PubMed ID: 12715450
    [No Abstract]   [Full Text] [Related]  

  • 38. [The amiodarone lung].
    Akoun G; Milleron B; Mayaud C
    Rev Pneumol Clin; 1984; 40(1):41-5. PubMed ID: 6372047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Formation of multiple round foci in the lung during amiodarone therapy].
    Criée CP; Wilhelms E; Kneba M; Kreuzer H
    Dtsch Med Wochenschr; 1984 Mar; 109(13):499-500. PubMed ID: 6705699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amiodarone-induced acute lung toxicity in an ICU setting.
    Venkatesan T; Ninan S
    Acta Anaesthesiol Scand; 2006 Apr; 50(4):520-1. PubMed ID: 16548873
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.